Darlifarnib, CAS [[3065226-39-0]]

Produktübersicht

• Artikelname: Darlifarnib, CAS [[3065226-39-0]]
• Artikelnummer: MCE-HY-172423
• Hersteller Artikelnummer: HY-172423
• Alternativnummer: MCE-HY-172423-1MG, MCE-HY-172423-5MG, MCE-HY-172423-500UG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: KO-2806

Produktbeschreibung

Darlifarnib (KO-2806) is an orally active farnesyl transferase inhibitor. Darlifarnib inhibits the mTORC1 signaling pathway, thereby enhancing the anti-angiogenic properties of tyrosine kinase inhibitors. When used in combination with anti-VEGFR tyrosine kinase inhibitors, Darlifarnib promotes renal cell carcinoma tumor regression and inhibits tumor neovascularization. Darlifarnib sensitizes renal cell carcinoma tumors that progress after anti-VEGFR TKI treatment[1].

Produkteigenschaften

• Molekulargewicht: 468.51
• CAS Nummer: [3065226-39-0]
• Formel: C29H20N6O
• Target-Kategorie: Farnesyl Transferase,mTOR,VEGFR

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound